Janus Henderson Group’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-6,200
Closed -$223K 2554
2024
Q4
$223K Hold
6,200
﹤0.01% 2389
2024
Q3
$235K Hold
6,200
﹤0.01% 2370
2024
Q2
$280K Sell
6,200
-58
-0.9% -$2.67K ﹤0.01% 2239
2024
Q1
$304K Buy
6,258
+1
+0% +$49 ﹤0.01% 2230
2023
Q4
$336K Sell
6,257
-10
-0.2% -$506 ﹤0.01% 2182
2023
Q3
$368K Buy
6,267
+1
+0% +$63 ﹤0.01% 2088
2023
Q2
$395K Sell
6,266
-6
-0.1% -$382 ﹤0.01% 2109
2023
Q1
$394K Buy
+6,272
New +$374K ﹤0.01% 2150
2022
Q2
Sell
-2,556
Closed -$203K 2687
2022
Q1
$203K Sell
2,556
-3
-0.1% -$270 ﹤0.01% 2435
2021
Q4
$259K Buy
+2,559
New +$255K ﹤0.01% 2267
2020
Q1
Sell
-11,797
Closed -$927K 1416
2019
Q4
$927K Buy
11,797
+377
+3% +$27.8K ﹤0.01% 1231
2019
Q3
$781K Buy
11,420
+2,346
+26% +$158K ﹤0.01% 1246
2019
Q2
$721K Buy
9,074
+1,947
+27% +$154K ﹤0.01% 1231
2019
Q1
$598K Buy
+7,127
New +$744K ﹤0.01% 1223
2018
Q4
Sell
-2,140
Closed -$258K 1420
2018
Q3
$258K Buy
+2,140
New +$266K ﹤0.01% 1404

Other funds holding USNA

Janus Henderson Group's USNA Position: Q1 2025 in Review

Janus Henderson Group sold out of Usana Health Sciences (USNA) in Q1 2025, closing a stake of 6,200 shares — an estimated $223K sold.

Janus Henderson Group first reported a position in USNA in Q3 2018 and held it in 15 quarters. The position peaked at $927K in Q4 2019. 162 funds tracked by Wall St. Rank hold USNA as of Q1 2025.

  • Janus Henderson Group reported no remaining Usana Health Sciences position as of Q1 2025 after selling out during the quarter.
  • Janus Henderson Group sold 6,200 Usana Health Sciences shares in Q1 2025, an estimated $223K.
  • Janus Henderson Group first reported a position in Usana Health Sciences in Q3 2018 and held it in 15 quarters.
  • Janus Henderson Group's Usana Health Sciences position peaked at $927K in Q4 2019.
  • 162 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2025.

Based on Janus Henderson Group's 13F filing for Q1 2025, filed 15 May 2025.